Reporting of an adverse event, a product quality problem or a product use error

Please call
Dr Gabriel Cozma (Head of Pharmacovigilance Unit): +41 79 337 76 91 or
Stéphane Michaut (Pharmacovigilance Coordinator) : +41 79 779 04 33
and send a fax to +41 22 783 11 80, stating your name, address, phone number and name of the product.

OM Pharma S.A. main contacts

CEO: Gianni Zampieri

DEPUTY MANAGING DIRECTOR: David Harar-Kenzey

INFORMATION AND COMMUNICATIONS: David Harar-Kenzey a.i.

BUSINESS DEVELOPMENT: David Harar-Kenzey a.i.
• Business development biological products: David Harar-Kenzey a.i.
• Business development synthetic products: Margaret Bergerioux
• Licensing-out R&D products: David Limal

HUMAN RESOURCES: Christian Pruneaud

QUALITY, ENVIRONMENT, SECURITY: Philippe Jaccard

RESEARCH & DEVELOPMENT: Jacques Bauer

MEDICAL & REGULATORY / PHARMACOVIGILANCE: Gabriel Cozma

COMMERCIAL
International Operations: Reto Baumann
• Export Europe: Myrta Keller
• Export Latin America: Laurent Taglialatela
• Export Middle East, Far East and Africa: Nicolas Ghosn

• Marketing & Sales Europe: Reto Baumann a.i.
• Marketing & Sales Latin America: Pierre Pialoux
• Marketing & Sales Middle East, Asia and Africa: Siham Azi
• International Marketing Manager: François Boualavong

PRODUCTION: Gilbert Fumex

FINANCE & ADMINISTRATION: David Harar-Kenzey

OM Pharma GROUP
• OM Pharma S.A. (Portugal): Antonio Jordao
• OM Pharma S.A. (Peru): Antonio Ciudad